confirmed that in NSCLC cells, miR-33a bound to the 3’-UTR of METTL3 mRNA, and thus, resulted in a decrease in m6A deposition and proliferation of cancer cells accompanied by the downregulation of METTL3 (79). The gene discussed is METTL3; the disease is cancer.